Aproele IPO Valuation Analysis
To value Aproele, we used an 18.2x P/E multiple based on our 2021 net profit estimate of 8.9 billion won. The valuation multiple of 18.2x was...
421 Views
SK Biopharmaceuticals Valuation Issues
One of the most debated issues during the book-building for SK Biopharm must be valuation.The bankers took an incredibly simple approach here. They...
450 Views
SK Holdings: Time to Take Profits
Given the tremendous recent outperformance of SK Holdings, we believe this is a good time to take some profits on this stock. SK Holdings (034730...
491 Views
SK Biopharm Valuation Analysis (What Is the Market Implying from SK Holdings?)
In this insight, we provide a valuation analysis of SK Biopharmaceuticals (BIO SK).Bullish Case Valuation - If we take a bullish case valuation...
480 Views
SK Biopharmaceuticals IPO: Potential Overhang Issue by SK Holdings
First, let me tell you this. The mood seems super hot on the SK Biopharm IPO. The book-building (overseas) is now in progress.And we are already...
505 Views